227 related articles for article (PubMed ID: 23547457)
21. Frequency of Epstein–Barr Virus DNA in Formalin-Fixed Paraffin-Embedded Tissue of Patients with Ductal Breast Carcinoma.
Sharifpour C; Makvandi M; Samarbafzadeh A; Talaei-Zadeh A; Ranjbari N; Nisi N; Azaran A; Jalilian S; Varnaseri M; Pirmoradi R; Ahmadi Angali K
Asian Pac J Cancer Prev; 2019 Mar; 20(3):687-692. PubMed ID: 30909665
[TBL] [Abstract][Full Text] [Related]
22. Sequence Variation Analysis of Epstein-Barr Virus Nuclear Antigen 1 Gene in the Virus Associated Lymphomas of Northern China.
Sun L; Zhao Z; Liu S; Liu X; Sun Z; Luo B
PLoS One; 2015; 10(10):e0140529. PubMed ID: 26460969
[TBL] [Abstract][Full Text] [Related]
23. EBNA1 sequences in Argentinean pediatric acute and latent Epstein-Barr virus infection reflect circulation of novel South American variants.
Lorenzetti MA; Altcheh J; Moroni S; Moscatelli G; Chabay PA; Preciado MV
J Med Virol; 2010 Oct; 82(10):1730-8. PubMed ID: 20827771
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
25. Molecular analysis of latent membrane protein 1 in patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Tabata YHibi S; Teramura T; Kuriyama K; Yagi T; Todo S; Sawada T; Imashuku S
Leuk Lymphoma; 2000 Jul; 38(3-4):373-80. PubMed ID: 10830744
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
Tierney RJ; Steven N; Young LS; Rickinson AB
J Virol; 1994 Nov; 68(11):7374-85. PubMed ID: 7933121
[TBL] [Abstract][Full Text] [Related]
27. Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal.
Neves M; Marinho-Dias J; Ribeiro J; Esteves M; Maltez E; Baldaque I; Breda E; Monteiro E; Medeiros R; Sousa H
J Med Virol; 2015 Aug; 87(8):1382-8. PubMed ID: 25879824
[TBL] [Abstract][Full Text] [Related]
28. Molecular Characterisation of Epstein-Barr Virus in Classical Hodgkin Lymphoma.
Begić V; Korać P; Gašparov S; Rozman M; Simicic P; Zidovec-Lepej S
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555277
[TBL] [Abstract][Full Text] [Related]
29. Infection of Epstein-Barr virus in colorectal cancer in Chinese.
Song LB; Zhang X; Zhang CQ; Zhang Y; Pan ZZ; Liao WT; Li MZ; Zeng MS
Ai Zheng; 2006 Nov; 25(11):1356-60. PubMed ID: 17094901
[TBL] [Abstract][Full Text] [Related]
30. Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms.
Lorenzetti MA; Gantuz M; Altcheh J; De Matteo E; Chabay PA; Preciado MV
J Clin Microbiol; 2012 Mar; 50(3):609-18. PubMed ID: 22205789
[TBL] [Abstract][Full Text] [Related]
31. Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.
Correia S; Palser A; Elgueta Karstegl C; Middeldorp JM; Ramayanti O; Cohen JI; Hildesheim A; Fellner MD; Wiels J; White RE; Kellam P; Farrell PJ
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515295
[TBL] [Abstract][Full Text] [Related]
32. Structural variability of the carboxy-terminus of Epstein-Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas.
Guiretti DM; Chabay PA; Valva P; Stefanoff CG; Barros MH; De Matteo E; Renault IZ; Preciado MV; Hassan R
J Med Virol; 2007 Nov; 79(11):1730-22. PubMed ID: 17854036
[TBL] [Abstract][Full Text] [Related]
33. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
Price AM; Messinger JE; Luftig MA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
[TBL] [Abstract][Full Text] [Related]
34. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
[TBL] [Abstract][Full Text] [Related]
35. Involvement of Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP)-1 in the potentiation of C epsilon mRNA expression in human tonsil-derived cells.
Ohta S; Hanashiro K; Sunagawa M; Tono T; Suzuki M; Kosugi T
Eur Arch Otorhinolaryngol; 2007 Mar; 264(3):245-50. PubMed ID: 17089136
[TBL] [Abstract][Full Text] [Related]
36. Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene.
Correa RM; Fellner MD; Alonio LV; Durand K; Teyssié AR; Picconi MA
J Med Virol; 2004 Aug; 73(4):583-8. PubMed ID: 15221903
[TBL] [Abstract][Full Text] [Related]
37. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
Shibata Y; Hoshino Y; Hara S; Yagasaki H; Kojima S; Nishiyama Y; Morishima T; Kimura H
J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
[TBL] [Abstract][Full Text] [Related]
38. LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1.
Bentz GL; Moss CR; Whitehurst CB; Moody CA; Pagano JS
J Virol; 2015 Aug; 89(15):7465-77. PubMed ID: 25948750
[TBL] [Abstract][Full Text] [Related]
39. Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China.
Chen JN; Ding YG; Feng ZY; Li HG; He D; Du H; Wu B; Shao CK
J Med Virol; 2010 Apr; 82(4):658-67. PubMed ID: 20166192
[TBL] [Abstract][Full Text] [Related]
40. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
